using semaglutide short term for Weight Loss: A Comprehensive Guide Semaglutide Side Effects: Short-Term vs.

Mounjaro (tirzepatide) is a new, injectable medication indicated for use in patients with type 2 diabetes

Coming soon - New 7.2mg dose of Wegovy Similar weight loss to Mounjaro 15mg Already approved in the U.S

Your prescriber needs to log the change in your medical record and confirm that the new schedule aligns with your current dose level and weight loss goals

In all, six of the 37 studies focused on semaglutide or tirzepatide, and most trial data followed patients for less than one year, meaning longer-term results are estimates

References Pollard, B., & Pomfrett, C

Weeks 1-8 (highest risk period): GI side effects are at their peak during initial dose escalation